INTELLECTUAL PROPERTY 2
Published patent application for the use of patient derived scaffolds within immune-oncology The patent application covers the use of cell-free scaffolds as a predictive tool in assessing cancer [...]
9. Breast Cancer Patient-Derived Scaffolds Can Expose Unique Individual Cancer Progressing Properties
Breast Cancer Patient-Derived Scaffolds Can Expose Unique Individual Cancer Progressing Properties of the Cancer Microenvironment Associated with Clinical Characteristics [...]
SLAS podcast on pre-clinical drug screening
Iscaffpharma interviewed on the importance of human microenvironment for pre-clinical drug screening. Listen here
8. 3D printed nanocellulose scaffolds as a cancer cell culture model system
8.-3d-printed-nanocellulose-scaffolds-as-a-cancer-cell-culture-model-system
7. Patient-derived scaffolds as a drug-testing platform for endocrine therapies
7.-patientderived-scaffolds-as-a-drugtesting-platform-for-endocrine-therapies-in-breast-cancer
6. Optimized alginate-based 3D printed scaffolds as a model of patient derived breast cancer microenvironments in drug discovery
Alginate-based 3D printed scaffolds used as a model of patient derived breast cancer micro-environments in drug discovery. [...]
New article on PDS and endocrine drug testing
Article on patient derived scaffolds used for drug testing of Endocrinol treatments.
5. Patient-derived scaffolds influence secretion profiles in cancer cells mirroring clinical features and breast cancer subtypes
PDSs repopulated with cancer cells can be used to assess how cancer secretion is effected by specific and varying microenvironments. Read full article here See information video [...]
4. Breast cancer patient-derived scaffolds as a tool to monitor chemotherapy responses in human tumor microenvironments
Patient derived scaffolds from breast cancer used to create unique fingerprints showing the potential in-vivo effect of chemotherapy. http://Breast cancer patient-derived scaffolds as a tool to [...]
